These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3114074)

  • 1. Multiple myeloma: biological and clinical significance of bone marrow plasma cell labelling index.
    Boccadoro M; Massaia M; Dianzani U; Pileri A
    Haematologica; 1987; 72(2):171-5. PubMed ID: 3114074
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kinetic studies on human myeloma cells following melphalan administration].
    Hara H; Nakai K; Nagai K
    Nihon Ketsueki Gakkai Zasshi; 1971 Oct; 34(5):614-21. PubMed ID: 5170343
    [No Abstract]   [Full Text] [Related]  

  • 3. [The percentage of bone marrow plasmacytes and prognosis in multiple myeloma].
    Paule B; Quillard J; Bennet P; Bisson M; Massias P
    Rev Rhum Mal Osteoartic; 1988 Dec; 55(12):969-72. PubMed ID: 3238308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell proliferation of myeloma plasma cells: comparison of the blood and marrow compartments.
    Kumar S; Rajkumar SV; Greipp PR; Witzig TE
    Am J Hematol; 2004 Sep; 77(1):7-11. PubMed ID: 15307099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
    Martín P; Santón A; Bellas C
    Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytopathological features of multiple myeloma].
    Takeuchi T; Adachi Y; Ikezoe T; Yokoyama A; Furihata M; Ohtsuki Y
    Nihon Rinsho; 2007 Dec; 65(12):2250-5. PubMed ID: 18069269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anit-immunoglobulins in multiple myeloma.
    Abdou NI; Abdou NL
    Clin Exp Immunol; 1972 May; 11(1):57-65. PubMed ID: 4537698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse niches within multiple myeloma bone marrow aspirates affect plasma cell enumeration.
    Nadav L; Katz BZ; Baron S; Yossipov L; Polliack A; Deutsch V; Geiger B; Naparstek E
    Br J Haematol; 2006 Jun; 133(5):530-2. PubMed ID: 16681641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial bone marrow findings in multiple myeloma. Significance of plasma cell nodules.
    Buss DH; Prichard RW; Hartz JW; Cooper MR; Feigin GA
    Arch Pathol Lab Med; 1986 Jan; 110(1):30-3. PubMed ID: 3753566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokinetic studies in human myeloma.
    Boccadoro M; Gavarotti P; Ciaiolo C; Golzio F; Omedè P; Redoglia V; Pileri A
    Basic Appl Histochem; 1986; 30(2):233-7. PubMed ID: 3741319
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma cell growth fraction using Ki-67 antigen expression identifies a subgroup of multiple myeloma patients displaying short survival within the ISS stage I.
    Gastinne T; Leleu X; Duhamel A; Moreau AS; Franck G; Andrieux J; Lai JL; Coiteux V; Yakoub-Agha I; Bauters F; Harousseau JL; Zandecki M; Facon T;
    Eur J Haematol; 2007 Oct; 79(4):297-304. PubMed ID: 17692103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of bone marrow angiogenesis in multiple myeloma.
    Rajkumar SV; Leong T; Roche PC; Fonseca R; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Kyle RA; Gertz MA; Greipp PR
    Clin Cancer Res; 2000 Aug; 6(8):3111-6. PubMed ID: 10955791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow plasma cell infiltration in multiple myeloma.
    de Gramont A; Benitez O; Smadja N; Brissaud P; Sirinelli A; Hubert D; Krulik M; Debray J
    Br J Haematol; 1984 Jun; 57(2):351-3. PubMed ID: 6733051
    [No Abstract]   [Full Text] [Related]  

  • 14. [Non-excretory plasma cell myeloma (apropos of 2 new cases)].
    Menkes CJ; Herreman G; Preud'homme JL; Godeau P; Delbarre F
    Nouv Presse Med; 1972 Jan; 1(5):309-12. PubMed ID: 4551593
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of bone marrow plasma cell kinetics in the differential diagnosis of monoclonal gammopathies].
    Pini E; Tassinari D; Gianni L; Fattori P; Sartori S; Pasquini E; Ravaioli A
    Recenti Prog Med; 1995 Jun; 86(6):242. PubMed ID: 7624585
    [No Abstract]   [Full Text] [Related]  

  • 16. CD74 is expressed by multiple myeloma and is a promising target for therapy.
    Burton JD; Ely S; Reddy PK; Stein R; Gold DV; Cardillo TM; Goldenberg DM
    Clin Cancer Res; 2004 Oct; 10(19):6606-11. PubMed ID: 15475450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of proliferative and clonogenic tumor cells in multiple myeloma.
    Karp JE; Burke PJ; Saylor PL; Humphrey RL
    Cancer Res; 1984 Sep; 44(9):4197-200. PubMed ID: 6744329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of aggressive multiple myeloma with cleaved, multilobated, and monocytoid nuclei, and no serum monoclonal gammopathy.
    Yeh YA; Pappas AA; Flick JT; Butch AW
    Ann Clin Lab Sci; 2000 Jul; 30(3):283-8. PubMed ID: 10945569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.
    Dezorella N; Pevsner-Fischer M; Deutsch V; Kay S; Baron S; Stern R; Tavor S; Nagler A; Naparstek E; Zipori D; Katz BZ
    Exp Cell Res; 2009 Jul; 315(11):1904-13. PubMed ID: 19328780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binucleated blast-cells in lymphocyte cultures from myelomatosis.
    Catovsky D; Holt PJ; Galton DA
    Immunology; 1972 Jun; 22(6):1103-9. PubMed ID: 5064147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.